A large number of people who have had bariatric surgery regain weight or never lose as much as expected, and GLP-1 drugs are increasingly prescribed into that gap. A 2024 meta-analysis pooled eight studies covering 557 individuals to ask whether it works and what it costs in body composition [1]. The answer to the first is yes. The answer to the second is where the interesting part is, and it overlaps with what happens to lean mass generally.
It works after surgery
Against placebo, liraglutide produced greater weight loss at six months by a mean difference of 6.0 kg (95% CI −8.66 to −3.33, P < 0.001), though with substantial heterogeneity between studies at I² = 79 per cent. Semaglutide outperformed liraglutide by 2.57 percentage points of body weight at six months (95% CI −3.91 to −1.23) and by 4.15 points at twelve (95% CI −6.96 to −1.34).
One included study reported that after twelve months semaglutide patients were more likely to reach more than 15 per cent weight loss (odds ratio 2.15, 95% CI 1.07 to 4.33) and more than 10 per cent (odds ratio 2.10, 95% CI 1.19 to 3.71), in 207 people.
What came off besides fat
On liraglutide, the pooled changes were a fat mass reduction of 4.78 kg (95% CI −7.11 to −2.45), a lean mass reduction of 3.01 kg (95% CI −4.80 to −1.22), and a whole-body bone mineral density reduction of 0.02 kg/m² (95% CI −0.04 to −0.00).
Read the last interval carefully. Its upper bound is zero, which means the analysis cannot rule out no bone effect at all — and it also cannot rule out a real one. The authors do not treat it as noise: their conclusion names deterioration of bone health and muscle mass as a concern needing further evaluation. In a post-surgical population, where bone density is already a known long-term issue, that combination matters more than it would in someone starting from scratch.
What this means for buying
Nothing about a post-bariatric prescription is visible in the way these drugs are sold online. A seller’s intake decides whether surgical history is asked about at all, and most of the sellers tracked here publish nothing about what a clinician reviews — the census is in what sellers publish. If you have had bariatric surgery, that is a reason to want a clinician who knows it, not just a prescription that arrives.
The practical points are bone and muscle rather than the drug. Resistance training and adequate protein are the standard advice for lean mass, and post-surgical patients usually already have a bone monitoring plan worth continuing. And a dose ladder is worth knowing in advance here too, since these are long courses — very few sellers publish one.
Which molecule a seller carries also decides what is available to you at all, and the molecule and format finder lists who offers what.